APA (7th ed.) Citation

C, B., FN, v. E., KP, R., SW, N., JW, B., VE, L., . . . IH, d. H. (2020). Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 46(10 Pt A), 1902. https://doi.org/10.1016/j.ejso.2020.04.018

Chicago Style (17th ed.) Citation

C, Bakkers, et al. "Long-term Survival After Hyperthermic Intraperitoneal Chemotherapy Using Mitomycin C or Oxaliplatin in Colorectal Cancer Patients with Synchronous Peritoneal Metastases: A Nationwide Comparative Study." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 46, no. 10 Pt A (2020): 1902. https://doi.org/10.1016/j.ejso.2020.04.018.

MLA (9th ed.) Citation

C, Bakkers, et al. "Long-term Survival After Hyperthermic Intraperitoneal Chemotherapy Using Mitomycin C or Oxaliplatin in Colorectal Cancer Patients with Synchronous Peritoneal Metastases: A Nationwide Comparative Study." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 46, no. 10 Pt A, 2020, p. 1902, https://doi.org/10.1016/j.ejso.2020.04.018.